Characteristics and 2‐year outcomes of dabigatran treatment in patients with heart failure and atrial fibrillation: GLORIA‐AF

Characteristics and 2‐year outcomes of dabigatran treatment in patients with heart failure and atrial fibrillation: GLORIA‐AF

Abstract Aims This study aimed to describe baseline characteristics of patients with atrial fibrillation (AF) at risk of stroke with and without history of heart failure (HF) and report 2‐year outcomes in the dabigatran‐treated subset of a prospective, global, observational study (GLORIA‐AF). Method...

Full description

Bibliographic Details
Main Authors: Sergio J. Dubner, Christine Teutsch, Menno V. Huisman, Hans‐Christoph Diener, Jonathan Halperin, Kenneth J. Rothman, Chang‐Sheng Ma, Eduardo Chuquiure‐Valenzuela, Jutta Bergler‐Klein, Kristina Zint, Lionel Riou França, Shihai Lu, Miney Paquette, Gregory Y.H. Lip
Format: Article
Language:English
Published: Wiley 2020-10-01
Series:ESC Heart Failure
Subjects:
Anticoagulation
Atrial fibrillation
Dabigatran
Heart failure
Major bleed
Stroke
Online Access:https://doi.org/10.1002/ehf2.12857

Internet

https://doi.org/10.1002/ehf2.12857

Similar Items